• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响肝细胞癌切除术后 5 年无病生存率的因素。

Factors resulting in 5-year disease-free survival after resection of hepatocellular carcinoma.

机构信息

Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.

出版信息

Anticancer Res. 2012 Apr;32(4):1417-22.

PMID:22493379
Abstract

BACKGROUND/AIM: Hepatectomy without recurrence for more than five years may be considered as being a sufficient resection of primary hepatocellular carcinoma (HCC). The purpose of the present study was to clarify the predictive factors for sufficient resection for HCC patients.

PATIENTS AND METHODS

In our Department, 77 patients with HCC survived without recurrence for more than five years following hepatectomy (curative group) and 187 patients underwent hepatectomy but developed recurrence within five years (recurrence group). We compared the clinicopathology between these two groups and evaluated the favorable factors for HCC without recurrence using logistic regression analysis.

RESULTS

The curative group was associated with three independent factors by multivariate logistic regression analyses: tumor size, serum indocyanine green retention rate (ICG15) and anatomic wide hepatectomy (all p<0.05).

CONCLUSION

Sufficient resection is closely related to patient, tumor, and treatment factors. Anatomic wide hepatectomy for small (<29 mm) HCC in patients with sufficient liver function (ICG15 <16.5%) can achieve sufficient resection.

摘要

背景/目的:无复发生存超过五年的肝癌切除术可被视为原发性肝癌(HCC)的充分切除术。本研究的目的是阐明 HCC 患者充分切除的预测因素。

患者和方法

在我院,77 例 HCC 患者行肝切除术后无复发且存活超过五年(治愈组),187 例患者行肝切除术但在五年内复发(复发组)。我们比较了两组的临床病理特征,并通过逻辑回归分析评估了 HCC 无复发的有利因素。

结果

多因素逻辑回归分析显示,治愈组与三个独立因素相关:肿瘤大小、血清吲哚菁绿滞留率(ICG15)和解剖性广泛肝切除术(均 p<0.05)。

结论

充分切除与患者、肿瘤和治疗因素密切相关。对于肝功能充足(ICG15<16.5%)的小 HCC(<29mm)患者,进行解剖性广泛肝切除术可实现充分切除。

相似文献

1
Factors resulting in 5-year disease-free survival after resection of hepatocellular carcinoma.影响肝细胞癌切除术后 5 年无病生存率的因素。
Anticancer Res. 2012 Apr;32(4):1417-22.
2
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
3
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.小肝癌患者行肝段切除术或肝叶切除术:20 年经验回顾
Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.
4
Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function.重新探讨肝功能良好的小肝癌(直径≤4cm 且单发)行非解剖性肝切除的作用。
J Surg Res. 2010 May 1;160(1):81-9. doi: 10.1016/j.jss.2009.01.021. Epub 2009 Feb 21.
5
Systematic hepatectomy for small hepatocellular carcinoma in Korea.韩国小肝细胞癌的系统性肝切除术
J Hepatobiliary Pancreat Surg. 2005;12(5):365-70. doi: 10.1007/s00534-005-1002-3.
6
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes.肝细胞癌切除术后早期复发相关因素及预后
J Am Coll Surg. 2006 Feb;202(2):275-83. doi: 10.1016/j.jamcollsurg.2005.10.005. Epub 2005 Dec 19.
7
Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.肝细胞癌肝切除术后的复发模式:米兰标准应用的意义。
Ann Surg Oncol. 2009 Jun;16(6):1560-71. doi: 10.1245/s10434-009-0407-7. Epub 2009 Mar 4.
8
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.肝细胞癌肝切除术后复发:危险因素、治疗及预后
Surgery. 2007 Mar;141(3):330-9. doi: 10.1016/j.surg.2006.06.028. Epub 2006 Nov 1.
9
Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.手术对微血管侵犯阴性肝细胞癌患者无复发生存率的影响
J Am Coll Surg. 2009 Mar;208(3):368-74. doi: 10.1016/j.jamcollsurg.2008.10.031.
10
Anatomic versus non-anatomic resection for small single hepatocellular carcinomas.小的单发肝细胞癌的解剖性切除与非解剖性切除
Hepatogastroenterology. 2007 Sep;54(78):1766-9.

引用本文的文献

1
Antiproliferative Activity of the Chinese Medicinal Compound, Delisheng, Compared With Rg3 and Gemcitabine in HepG2 Cells.中药复方得力生与Rg3及吉西他滨对HepG2细胞增殖抑制作用的比较
Indian J Pharm Sci. 2013 Sep;75(5):578-84.